Minerva Imaging
Frederikke Petrine Fliedner is a seasoned professional in the field of scientific business development, currently serving as the Senior Scientific Business Developer and Head of Preclinical Services at Minerva Imaging since September 2020. Prior to this role, Frederikke accumulated valuable experience at the Cluster for Molecular Imaging from January 2014 to August 2020, where positions included PhD Student, Research Assistant, and Master Student. Frederikke began a career in research at Ferring Pharmaceuticals as a Student Researcher from February 2013 to February 2014. Academically, Frederikke holds a Doctor of Philosophy (PhD) in Molecular Imaging in Oncology, obtained from Københavns Universitet - University of Copenhagen between June 2016 and April 2021, along with a Cand.Scient degree in Biology-Biotechnology (2012-2015) and a Bachelor of Science (B.Sc.) in Biology-Biotechnology (2009-2012) from the same institution.
This person is not in any offices
Minerva Imaging
Minerva Imaging is a contract research organization specializing in molecular imaging services for accelerated and efficient drug development. We help our clients to reduce the cost and risk of drug development by incorporating preclinical imaging early in the process. In collaboration with our clients we design and conduct tailored molecular imaging protocols to i.e measure drug on target effects, eliminate dead end compounds, and increase the value of lead drug candidates. We facilitate clinical testing and design of adaptive clinical trials using molecular imaging to increase the speed of clinical testing.